Review
doi: 10.1016/j.micinf.2009.07.011.
Epub 2009 Aug 4.
Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease
Affiliations
- PMID: 19660570
- DOI: 10.1016/j.micinf.2009.07.011
Item in Clipboard
Review
Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease
Microbes Infect.
2009 Nov.
Free article
Abstract
The physiopathology of Chagas' disease has been largely defined in murine infections with virulent strains which partially represent parasite diversity. This report reviews our studies with Sylvio X10/4 parasites, a Trypanosoma cruzi clone that induces no acute phase but in C3H/He mice leads to chronic myocarditis resembling the human disease.
Similar articles
-
Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source.Am J Trop Med Hyg. 1983 May;32(3):497-506. doi: 10.4269/ajtmh.1983.32.497. Am J Trop Med Hyg. 1983. PMID: 6407346
-
IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.Scand J Immunol. 2007 Aug-Sep;66(2-3):297-308. doi: 10.1111/j.1365-3083.2007.01958.x. Scand J Immunol. 2007. PMID: 17635807
-
Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease.Infect Immun. 2004 Apr;72(4):2350-7. doi: 10.1128/IAI.72.4.2350-2357.2004. Infect Immun. 2004. PMID: 15039360 Free PMC article.
-
Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.Parasitol Int. 2008 Jun;57(2):105-9. doi: 10.1016/j.parint.2007.12.008. Epub 2007 Dec 23. Parasitol Int. 2008. PMID: 18234547 Review.
-
The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?N Biotechnol. 2010 Dec 31;27(6):837-43. doi: 10.1016/j.nbt.2010.02.003. Epub 2010 Feb 19. N Biotechnol. 2010. PMID: 20172059 Review.
Cited by
-
Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi.Front Immunol. 2020 Feb 21;11:128. doi: 10.3389/fimmu.2020.00128. eCollection 2020. Front Immunol. 2020. PMID: 32153562 Free PMC article.
-
Translational challenges of animal models in Chagas disease drug development: a review.Drug Des Devel Ther. 2015 Aug 19;9:4807-23. doi: 10.2147/DDDT.S90208. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26316715 Free PMC article. Review.
-
Neuroprotective Treatments for Digestive Forms of Chagas Disease in Experimental Models: A Systematic Review.Oxid Med Cell Longev. 2022 Sep 25;2022:9397290. doi: 10.1155/2022/9397290. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36199427 Free PMC article.
-
The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease.PLoS One. 2014 Mar 20;9(3):e91640. doi: 10.1371/journal.pone.0091640. eCollection 2014. PLoS One. 2014. PMID: 24651711 Free PMC article.
-
Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic Trypanosoma cruzi Infection.Front Immunol. 2018 May 7;9:997. doi: 10.3389/fimmu.2018.00997. eCollection 2018. Front Immunol. 2018. PMID: 29867974 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
